ClinicalTrials.gg
CompletedNCT07887100Updated Oct 21, 2026

Plantar Fascia Thickness and Pedobarometric Parameters in Sacroiliac Joint Dysfunction

An observational study in Sacroiliac Joint Dysfunction, Plantar Fascia Thickness and Pedobarography, sponsored by Dokuz Eylul University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-21.

Sponsored by Dokuz Eylul University · Observational

Updated Oct 21, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
52
Ages
18 Years to 50 Years
Sex
All
01

Study summary

This study aims to compare plantar fascia thickness and pedobarometric parameters between individuals with sacroiliak joint dysfunction and healty individuals.A total of 52 adult volunteers aged 18 to 50 years were included in the study, with 26 pariticipants in the sacroiliac joint dysfunction group and 26 participants in the healty control group.Participants with sacroiliac joint dysfunction were identified based on clinical examination and sacroiliac joint pain provocation tests. Foot posture was evaluated using the Foot Posture Index-6 (FPI-6), and participants with neutral foot posture were included. Plantar fascia thickness of both feet was measured using ultrasound. Static foot pressure measurements were performed during standing with eyes open and closed, and dynamic foot pressure measurements were performed during walking using a pedobarometric system. The study compares plantar fascia thickness and pedobarometric parameters between the sacroiliak joint dysfunction and control groups. It also investigates the relationship between plantar fascia thickness and pedobarometric parameters.

Read the detailed description

This cross-sectional, comparative case-control study was designed to compare plantar fascia thickness and pedobarometric parameters between patients with sacroiliac joint dysfunction (SIJD) and healthy controls, and to examine the relationship between plantar fascia thickness and pedobarometric parameters in the patient group.

Patients aged 18 to 50 years who presented with low back pain to the Physical Medicine and Rehabilitation outpatient clinic of Dokuz Eylul University Faculty of Medicine and met the eligibility criteria were enrolled consecutively. The control group consisted of healthy volunteers without SIJD, selected to be similar to the patient group in age, sex, and body mass index (BMI). Controls were recruited from the staff of the Faculty of Medicine and the Faculty of Physical Therapy and Rehabilitation and through announcements in these units. Written informed consent was obtained from all participants. The minimum sample size, calculated with G*Power 3.1.9.7 (d = 0.80, alpha = 0.05, power = 80%), was 26 participants per group (52 in total).

Age, sex, occupation, height, weight, BMI, weekly exercise duration, daily step count, comorbidities, lower limb length discrepancy, and dominant foot were recorded. All assessments were completed on the same day by the same investigator, who was not blinded to group status.

SIJD was diagnosed in patients with pain around the posterior superior iliac spine when at least three of six provocation tests (FABER, Gaenslen, thigh thrust, sacral thrust, compression, and distraction) were positive on the same side. A test was considered positive when it reproduced the patient's familiar pain, and the affected side was recorded.

Foot posture was assessed with the Foot Posture Index-6 (FPI-6), which consists of six items with a total score ranging from -12 to +12. Only participants with scores between 0 and +5 (neutral foot posture) in both feet were included.

Plantar fascia thickness was measured by ultrasonography (GE Versana Premier, 4.2-13 MHz linear probe) with the participant lying prone. Measurements were taken in the sagittal plane at the calcaneal insertion of the fascia, and the mean of three measurements was recorded for each foot. Echogenicity, calcaneal spur, perifascial fluid, and Doppler vascularity were also recorded.

Pedobarometric assessment was performed barefoot on a TekScan MatScan pressure mat. Static measurements lasted 30 seconds and were taken with eyes open and eyes closed. Dynamic measurements were taken with the three-step protocol in both walking directions, so that each foot was recorded separately. Each measurement was repeated three times and averaged. Center of force (CoF) parameters (ellipse area, path length, variability, and anteroposterior and mediolateral excursion) and load distribution (% body weight) were recorded.

Data collection has been completed, and statistical analyses will be performed with IBM SPSS Statistics version 27. Depending on the distribution of the data, continuous variables will be compared between groups with the independent-samples t test or the Mann-Whitney U test, and categorical variables with the chi-square or Fisher's exact test. Associations between plantar fascia thickness and pedobarometric parameters will be assessed with Pearson or Spearman correlation analysis.Multivariable linear regression analysis will be used to identify factors associated with plantar fascia thickness.The Benjamini-Hochberg false discovery rate procedure will be applied for multiple comparions where appropriate. Effect sizes and 95% confidence intervals will be reported together with p values, and p \< 0.05 will be considered statistically significant.

02

Conditions studied

  • Sacroiliac Joint Dysfunction
  • Plantar Fascia Thickness
  • Pedobarography
  • Foot Posture Index Score
  • Pedobarometric

Keywords

  • Sacroiliac Joint Dysfunction
  • Plantar fascia thickness
  • pedobarography
  • Foot Posture Index Score
  • pedobarometric
03

In context

Lead sponsor

Dokuz Eylul University is the lead sponsor of 257 studies on the registry; 34 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Patients with sacroiliac joint dysfunction were enrolled consecutively from individuals aged 18 to 50 years who presented with low back pain to the Physical Medicine and Rehabilitation outpatient clinic of Dokuz Eylul University Faculty of Medicine. Healthy volunteers of the same age range were recruited as controls from the staff of Dokuz Eylul University Faculty of Medicine and Faculty of Physical Therapy and Rehabilitation and through announcements in these units

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Sacroiliac joint dysfunction group:

  • Age 18 to 50 years
  • Low back pain for at least 3 months, localized mainly around the posterior superior iliac spine, with or without radiation to the buttock or posterior thigh
  • At least three of six sacroiliac joint pain provocation tests (FABER, Gaenslen, thigh thrust, sacral thrust, compression, and distraction) positive on the same side
  • Foot Posture Index-6 score between 0 and +5 in both feet

Healthy control group:

  • Age 18 to 50 years
  • No diagnosis of sacroiliac joint dysfunction and no related complaints (all six sacroiliac joint pain provacation tests (FABER, Gaenslen, thigh thrust, sacral thrust, compression, and distraction) negative bilaterally )
  • Foot Posture Index-6 score between 0 and +5 in both feet

Exclusion criteria

Exclusion Criteria:

  • Systemic rheumatologic disease (e.g., rheumatoid arthritis, ankylosing spondylitis)
  • Metabolic bone disease (e.g., osteoporosis, osteomalacia)
  • Active lumbar disc herniation or radiculopathy
  • Previous fracture, surgery, or structural deformity of the lower extremity
  • Pregnancy
  • Body mass index above 30 kg/m2
  • Diabetes mellitus and/or hypothyroidism
  • Regular exercise on more than three days per week
  • Occupation requiring prolonged standing (e.g., teacher, surgeon, waiter)
  • Walking more than 5 km per day
  • Physical therapy and/or injection treatment to the foot or ankle within the past 6 months
  • Previous diagnosis or history of plantar fasciitis
  • Central or peripheral nervous system disease (e.g., stroke, peripheral neuropathy, tarsal tunnel syndrome, Morton's neuroma)
  • Lower extremity length discrepancy of 1 cm or more
  • Use of orthopedic insoles, special footwear, or orthoses
  • History of serious foot trauma (e.g., moderate to severe ankle sprain)
05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
52 participants (actual)
Patient registry
No

Groups and cohorts

  • Sacroiliac Joint Dysfunction Group

    Patients with low back pain who were diagnosed with sacroiliac joint dysfunction when at least three of six pain provocation tests were positive on the same side. No intervention was applied. Plantar fascia thickness was measured by ultrasonography, and static and dynamic pedobarometric assessments were performed.

  • Healthy Control Group

    Healthy volunteers without sacroiliac joint dysfunction, selected to be similar to the patient group in age, sex, and body mass index. No intervention was applied. Participants underwent the same ultrasonographic and pedobarometric assessments as the patient group.

06

What researchers measure

Primary outcomes

  1. Plantar Fascia Thickness

    Plantar fascia thickness was measured by ultrasonography in the sagittal plane at the calcaneal insertion of the fascia. Three measurements were taken for each foot, and their mean was recorded in millimeters.

    Time frame: At enrollment (single assessment visit)

  2. Center of Force Ellipse Area

    Center of force (CoF) ellipse area was measured with a TekScan MatScan pressure mat under static (eyes open and eyes closed) and dynamic (three-step protocol) conditions. Each measurement was repeated three times, and the mean was recorded in square centimeters.

    Time frame: At enrollment (single assessment visit)

  3. Center of Force Path Length

    Center of force (CoF) path length was measured with a TekScan MatScan pressure mat under static (eyes open and eyes closed) and dynamic (three-step protocol) conditions. Each measurement was repeated three times, and the mean was recorded in centimeters.

    Time frame: At enrollment (single assessment visit)

  4. Center of Force Variability

    Center of force (CoF) variability was measured with a TekScan MatScan pressure mat under static (eyes open and eyes closed) and dynamic (three-step protocol) conditions. Each measurement was repeated three times, and the mean was recorded in centimeters.

    Time frame: At enrollment (single assessment visit)

  5. Center of Force Anteroposterior Excursion

    Center of Force Anteroposterior Excursion was measured with a TekScan MatScan pressure mat under static (eyes open and eyes closed) and dynamic (three-step protocol) conditions. Each measurement was repeated three times, and the mean was recorded in centimeters.

    Time frame: At enrollment (single assessment visit)

  6. Center of Force Mediolateral Excursion

    Center of Force Mediolateral Excursion was measured with a TekScan MatScan pressure mat under static (eyes open and eyes closed) and dynamic (three-step protocol) conditions. Each measurement was repeated three times, and the mean was recorded in centimeters.

    Time frame: At enrollment (single assessment visit)

  7. Total Foot Load

    The percentage of body weight borne by each foot was measured with a TekScan MatScan pressure mat under static (eyes open and eyes closed) and dynamic (three-step protocol) conditions. Each measurement was repeated three times, and the mean was recorded as a percentage of body weight.

    Time frame: At enrollment (single assessment visit)

  8. Forefoot Load

    The percentage of body weight borne by the forefoot region of each foot was measured with a TekScan MatScan pressure mat under static (eyes open and eyes closed) and dynamic (three-step protocol) conditions. Each measurement was repeated three times, and the mean was recorded as a percentage of body weight.

    Time frame: At enrollment (single assessment visit)

  9. Rearfoot Load

    The percentage of body weight borne by the rearfoot region of each foot was measured with a TekScan MatScan pressure mat under static (eyes open and eyes closed) and dynamic (three-step protocol) conditions. Each measurement was repeated three times, and the mean was recorded as a percentage of body weight.

    Time frame: At enrollment (single assessment visit)

07

Study locations

1 site
  • Department of Physical Medicine and Rehabilitation, Medical Faculty of Dokuz Eylül University
    Izmir, 35330, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared, as the protocol approved by the ethics committee specifies that study data will not be shared with third parties.

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 21, 2026
Show all 1 update
  1. Oct 21, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07887100
Responsible party
Nihan ERDINC GUNDUZ (Associate Professor, Dokuz Eylul University) — Principal investigator
First posted
Oct 21, 2026
Start date
Mar 2, 2026
Primary completion
Sep 1, 2026
Completion
Sep 1, 2026
Last update
Oct 21, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion